COST OF THE MEDICARE ACT OF 2003
|
Recent press releases have revealed a large difference between the
original Congressional Budget Office (CBO) estimate of the costs of the
Medicare Act of 2003 and the Bush Administration’s subsequent budget
estimations. Following is a summation of those differences and the
explanations issued by the CBO. |
||
|
|
||
|
|
Administration
Estimate v. CBO estimate |
Reason for
the Difference According to the CBO |
|
Basic
Benefits |
The Administration figure is 7% or about 32 billion
higher than the CBO estimate. |
The Administration
assumes a higher participation rate of people with Medicare and
estimates per capita costs at 4% higher than the CBO estimates. CBO
excludes people who decline Part B and those in the Federal Employee
Health Benefits Program on the assumption that they generally will not
participate. |
|
|
|
|
|
Medicare
Advantage (Medicare + Choice or Medicare Managed Care) |
The Administration estimated $46 billion; a $32
billion increase from the CBO’s estimate. |
The Administration
projects more people to choose a managed care option than is projected
by the CBO (32% to 9%). As managed care is more costly than
fee-for-service plans, payments to managed care plans would be
substantially higher than payments if those beneficiaries remain in
fee-for-service Medicare. |
|
|
|
|
|
Low Income
Subsidy |
The Administration figure is about $47 billion
higher, a 24% difference. |
The Administration
assumes higher participation starting immediately. CBO ramps up
participation over three years, with a lower per capita cost estimate
based on participation rates in Medicare Savings Programs. |
|
|
|
|
|
Savings to
Medicaid |
The Administration estimates a reduction in
Medicaid spending of $123 billion as opposed to the CBO’s projected
$141 billion. |
Both organizations
project a savings that will be offset by the additional costs of
enrolling new people into Medicaid. CBO’s estimate is higher largely
due to differences in baseline projections for Medicaid spending on
waiver programs which provide limited drug coverage to low-income
Medicare beneficiaries who do not otherwise qualify for Medicaid. |
|
|
||
© Center for Medicare Advocacy, Inc. 01/08/2010